Results of autologous stem cell transplant in multiple myeloma patients with renal failure. - Wikidata - awgldk - TriplyDB

Results of autologous stem cell transplant in multiple myeloma patients with renal failure.

Results of autologous stem cell transplant in multiple myeloma patients with renal failure.

http://www.wikidata.org/entity/Q43742768

about

Current Trends of Renal Impairment in Multiple Myeloma The Prevalence and Management of Multiple Myeloma-Induced Kidney Disease in China Fifty years of melphalan use in hematopoietic stem cell transplantation Treatment of autologous stem cell transplant-eligible multiple myeloma patients: ten questions and answers Use of bortezomib as induction therapy prior to stem cell transplantation in frontline treatment of multiple myeloma: impact on stem cell harvesting and engraftment.Bortezomib before and after autologous stem cell transplantation overcomes the negative prognostic impact of renal impairment in newly diagnosed multiple myeloma: a subgroup analysis from the HOVON-65/GMMG-HD4 trial.Novel therapies in multiple myeloma for newly diagnosed nontransplant candidates CD34+/CD45-dim stem cell mobilization by hyperbaric oxygen - changes with oxygen dosage Multiple myeloma in Niger Delta, Nigeria: complications and the outcome of palliative interventions.Population pharmacokinetics of melphalan in patients with multiple myeloma undergoing high dose therapy.Autologous hematopoietic stem cell transplantation may reverse renal failure in patients with multiple myeloma.Arsenic trioxide with ascorbic acid and high-dose melphalan: results of a phase II randomized trial How we manage autologous stem cell transplantation for patients with multiple myeloma Predicting long-term survival in multiple myeloma patients following autotransplants.Renal insufficiency retains adverse prognostic implications despite renal function improvement following Total Therapy for newly diagnosed multiple myeloma.Autologous Hematopoietic Stem Cell Transplantation in Dialysis-Dependent Myeloma Patients.Determination of intrarenal resistance index (RI) in patients with multiple myeloma.Current treatment options for myeloma.Role of allogeneic stem cell transplantation in multiple myeloma.Cure of multiple myeloma -- more hype, less reality.Variability of high-dose melphalan exposure on oral mucositis in patients undergoing prophylactic low-level laser therapy.High-dose chemotherapy with autologous hematopoietic stem cell transplantation in patients with multiple myeloma.Melphalan Culprit or Confounder in Acute Encephalopathy during Autologous Hematopoietic Stem Cell Transplantation?High-dose melphalan-based autotransplants for multiple myeloma: the Arkansas experience since 1989 in 3077 patients.Melphalan: old and new uses of a still master drug for multiple myeloma.The Arkansas approach to therapy of patients with multiple myeloma.High melphalan exposure is associated with improved overall survival in myeloma patients receiving high dose melphalan and autologous transplantation.Melphalan 180 mg/m2 can be safely administered as conditioning regimen before an autologous stem cell transplantation (ASCT) in multiple myeloma patients with creatinine clearance 60 mL/min/1.73 m2 or lower with use of palifermin for cytoprotection:Treatment of multiple myeloma: a comprehensive review.How we approach patient evaluation for hematopoietic stem cell transplantation.Renal failure in multiple myeloma: a medical emergency.Guidelines for the diagnosis and management of multiple myeloma 2011.Novel approaches for reducing free light chains in patients with myeloma kidney.Renal allografts in plasma cell myeloma hematopoietic cell graft recipients: on the verge of an explosion?Addressing the questions of tomorrow: melphalan and new combinations as conditioning regimens before autologous hematopoietic progenitor cell transplantation in multiple myeloma.Current treatments for renal failure due to multiple myeloma.Not too little, not too much-just right! (Better ways to give high dose melphalan).Autologous hematopoietic cell transplantation: an update for clinicians.Melphalan hydrochloride for the treatment of multiple myeloma.Italian consensus conference for the outpatient autologous stem cell transplantation management in multiple myeloma.

P2860

Q26740444-4047CEE5-DC47-4BF5-A22D-3069849E13F0 Q26740446-5F5A7FA9-ABBC-49C0-8323-F003157BA1A2 Q26824498-98DFBB5D-5182-4439-A6B6-D60A153F9A12 Q26851202-A1D506EF-1E4D-4DAE-8E04-7DBB5298C759 Q33376918-2BC7D3AB-8BD2-437C-9EA4-AFA42A83EE59 Q33558161-F2D066CC-5B05-47CC-99C1-ECDAB5AD016D Q33639796-DE5ABDA7-CC62-4A77-90EB-1668DC4B52D3 Q33681013-A9A20ACF-9F39-4D8A-9CAC-B249FE61DC45 Q33734421-C9875390-825A-495B-B2B2-15DC096493F6 Q33795058-CD3CDAF3-5F2A-4D69-9798-341219C1F15A Q33956039-52794289-CA57-47E7-AB31-0FB5A2565EEE Q33956059-AA15DBFE-58F9-4926-8908-601AC9746BF0 Q34019581-8F15EDB1-5002-4810-9B8E-05541EB0B86D Q35152606-CA363924-F7AC-49FC-97C3-4747772B7336 Q35603608-AF79FF08-7F80-4A99-8AE5-D9F74F162EB5 Q35893993-36D32B6D-A4EB-4BA4-99AB-5D77C7B0C70E Q35959247-CF0CFB11-DC23-46C0-BDDD-CC5DA4F2055F Q36163971-5DB38943-A07E-4609-AD1F-73180D12E28D Q36185617-52A744FA-85A6-44D3-9F85-51370AFAC486 Q36301128-95B6F708-DA55-40E8-B551-8B6E7EA6743E Q36373735-0EC7E11A-87FD-4487-8634-E14DE0F0B201 Q36407446-FBA40BE9-12DB-491F-BDBE-14A7A4B33ED7 Q36422184-E324ADE1-AA59-4F4A-9FA0-B6336A779E72 Q36838506-9BE098A5-1FA8-42BE-99C2-298B96DE5D67 Q36916889-E25DEDA4-0F3D-4127-ABA6-0B43F43E38A6 Q37028586-CB4E67EB-83D2-4067-9ECC-AB84EA4CA168 Q37030719-9A627A49-8DCF-4BFA-BC37-4DBD25AD7AD6 Q37195567-DFA59C31-43C7-4B2D-9244-FBCECC57AF7D Q37542173-B07C611E-A4A4-42EE-AA40-7CFD1D768801 Q37755957-45AF214E-C990-4F3F-894E-DFDFA759D4B4 Q37845643-280A2368-D42A-45F6-B991-73F94ECFCFE6 Q37875193-B3EA37C2-DB1B-4AD2-B69E-7918CB674CD1 Q37986358-C633FEBB-7A35-4468-A71B-F58B23DCED18 Q38021620-8B960D58-6443-44F2-9683-BB47AFCE149D Q38095526-07868E35-D1EA-4B4B-BE83-DEF53517C521 Q38109235-8102BDEC-612E-4507-B1FC-F735571C20FC Q38240941-E7928061-5CFB-4CD1-AF36-E5B00C1B8070 Q38248359-23416A36-CFE5-4F73-BBE3-65529ACC0C94 Q38704146-77ACB732-B612-4EFB-9B29-573AD618631A Q38797546-C47BE16A-E59D-4F3A-A1FE-D404195E7A20

P2860

Results of autologous stem cell transplant in multiple myeloma patients with renal failure.

http://www.wikidata.org/entity/Q43742768

description

2001 nî lūn-bûn

@nan

2001年の論文

@ja

2001年学术文章

@wuu

2001年学术文章

@zh

2001年学术文章

@zh-cn

2001年学术文章

@zh-hans

2001年学术文章

@zh-my

2001年学术文章

@zh-sg

2001年學術文章

@yue

2001年學術文章

@zh-hant

name

Results of autologous stem cel ...... a patients with renal failure.

@en

Results of autologous stem cel ...... a patients with renal failure.

@nl

type

label

Results of autologous stem cel ...... a patients with renal failure.

@en

Results of autologous stem cel ...... a patients with renal failure.

@nl

prefLabel

Results of autologous stem cel ...... a patients with renal failure.

@en

Results of autologous stem cel ...... a patients with renal failure.

@nl

P1433

Q43742768-0473DB99-ED19-43A0-BB65-603337DF278E

P1476

Q43742768-17EE4739-83CE-4A1E-9913-93DF8ECB7039

P2093

Q43742768-296C5DC5-E85C-4E2A-989A-42DD3119B8AB

Q43742768-30743635-C388-44A0-B024-4FBEE91410A9

Q43742768-489B02D4-7102-43E7-9F03-E136ED0DE13F

Q43742768-4C326C02-9910-49EC-8335-B7CF5CC4BE9C

Q43742768-78246802-8457-4B1D-AC8B-3F2FFB671A0B

Q43742768-9337A743-5471-4743-A602-100C3B87B9D5

Q43742768-9AE03C66-1C9D-4BB0-8F43-48AF8371BE43

Q43742768-A6915695-1CCF-4730-AFC0-5875A543D0FC

Q43742768-B308A88B-398F-46C5-B90D-CE6A1E4F65C2

Q43742768-BDB541AC-1C85-42FA-A122-6E68870B3E19

P2860

Q43742768-06F68718-2487-4EC3-8DAA-EED98F036437

Q43742768-260ED12B-6E34-4949-9466-DC393B035B0B

Q43742768-5EDB91E9-78E9-4016-9522-7B17899B6164

Q43742768-60C8F26C-7AD5-4F3C-B96E-31F287313B58

Q43742768-789E9206-8FF2-4D0F-947C-760024101509

Q43742768-A29269CB-BF44-409B-9832-D96E324D1A6F

Q43742768-A338F9E7-50A7-4E8D-A274-8CF7FA6A9CD6

Q43742768-AB083F11-CED9-47DE-BADB-BE97151A9EDF

Q43742768-B97DAD3B-49B7-465A-95DE-E964E57FFDC5

Q43742768-BF108372-F819-4E77-ABC5-5F3B8A450946

P304

Q43742768-69D66653-87F6-4618-A32E-733A33AA329E

P31

Q43742768-1A17D96B-1324-4163-929A-8E6B6D9230E8

P356

Q43742768-2C0B88DA-BA71-4E93-AB47-CF4BB2353494

P407

Q43742768-EAE8D72E-615C-4006-A40A-A59392D39347

P433

Q43742768-AD8BFB2B-03A8-4DE0-BB48-C2249D2B2525

P478

Q43742768-BC3B7635-BF82-44AC-AC11-6FBBE7FC506B

P577

Q43742768-F18166B4-EDDC-4BF8-9EE6-6FBA4A766C3B

P5875

Q43742768-3C0AFBA7-52EF-4A83-A95B-7C736E8E9B03

P698

Q43742768-DBB943A4-2D57-43F2-9B18-02EA1CAA6871

P356

J.1365-2141.2001.03033.X

P1433

British Journal of Haematology

P1476

Results of autologous stem cel ...... a patients with renal failure.

@en

P2093

Anaissie E

http://www.w3.org/2001/XMLSchema#string

Badros A

http://www.w3.org/2001/XMLSchema#string

Barlogie B

http://www.w3.org/2001/XMLSchema#string

Barri Y

http://www.w3.org/2001/XMLSchema#string

Desikan R

http://www.w3.org/2001/XMLSchema#string

Fassas A

http://www.w3.org/2001/XMLSchema#string

Langmaid C

http://www.w3.org/2001/XMLSchema#string

McConnell S

http://www.w3.org/2001/XMLSchema#string

Munshi N

http://www.w3.org/2001/XMLSchema#string

Muwalla F

http://www.w3.org/2001/XMLSchema#string

P2860

Encephalopathy complicating high-dose melphalan

Comparison of vincristine, carmustine, melphalan, cyclophosphamide, prednisone (VBMCP) and interferon-alpha with melphalan and prednisone (MP) and interferon-alpha (IFN-alpha) in patients with good-prognosis multiple myeloma: a prospective randomize

The role of continuous ambulatory peritoneal dialysis in end-stage renal failure due to multiple myeloma.

Effect of high-dose melphalan and peripheral blood stem cell transplantation on renal function in patients with multiple myeloma and renal insufficiency: a case report and review of the literature.

A clinical staging system for multiple myeloma. Correlation of measured myeloma cell mass with presenting clinical features, response to treatment, and survival.

Treatment of renal failure associated with multiple myeloma. Plasmapheresis, hemodialysis, and chemotherapy.

High-dose intravenous melphalan: a review.

Management of myeloma kidney: an anti-light-chain approach.

Presentation and survival of patients with severe renal failure and myeloma.

Peripheral blood stem cell transplantation in a multiple myeloma patient with end-stage renal failure

P304

822-829

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1046/J.1365-2141.2001.03033.X

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

114

http://www.w3.org/2001/XMLSchema#string

P577

2001-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

227603747

http://www.w3.org/2001/XMLSchema#string

P698

11564069

http://www.w3.org/2001/XMLSchema#string